Why Bionano Genomics Stock Soared Today
Shares of Bionano Genomics (NASDAQ: BNGO) surged 20.6% on Monday after the biotech company began its Next-Generation Cytogenomics Symposium, during which potential applications of its Saphyr optical genome mapping (OGM) system were discussed.
Bionano Genomics published a study that used Saphyr to identify structural variants (SVs) in genes that control immune and inflammatory responses. The results of the study could shed light on why COVID-19 causes some people to become severely ill.
Source Fool.com